CEPI Revenue and Competitors

Oslo, Norway

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • CEPI's estimated annual revenue is currently $32.4M per year.(i)
  • CEPI's estimated revenue per employee is $112,200

Employee Data

  • CEPI has 289 Employees.(i)
  • CEPI grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.8M14121%N/AN/A
#2
$32.4M28911%N/AN/A
#3
$31.5M2816%N/AN/A
#4
$110.1M77119%N/AN/A
#5
$21.2M18911%N/AN/A
#6
$52.9M41513%N/AN/A
#7
$0.9M15-12%N/AN/A
#8
$0.7M129%N/AN/A
Add Company

CEPI - Coalition for Epidemic Preaparedness Innovations - is a new broad international coalition set up to fund development of vaccines against emerging infectious diseases with epidemic potential, where there are few market incentives. The epidemics like Ebola and SARS we have seen over the past years, have demonstrated the need for vaccines. Development of a vaccine takes many years, and it is too late to start when the outbreak has started. By having vaccines on the shelf ready for phase III early in an outbreak, we can demonstrate the vaccine efficacy and stop the outbreak while it is small. CEPI has already launched two calls for proposals; one for development of vaccines against MERS, Lassa and Nipah and one for the development of rapid response vaccine technology to enable development of vaccines against new and unknown diseases. CEPI was launched in January 2017 and now has funding totalling $620 million from soverign investors and philantropic institutions. CEPI's investors are: The Governments of Australia, Belgium, Canada, Japan and Norway, as well as the Wellcome Trust and the Bill&Melinda Gates Foundation. In addition the European Commission will co fund activities with 250 million.

keywords:N/A

N/A

Total Funding

289

Number of Employees

$32.4M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CEPI News

2022-04-06 - CEPI's moon shot: Developing pandemic vaccines in 100 days

The Coalition for Epidemic Preparedness Innovations, or CEPI, launched a multi-billion dollar plan to accelerate the development and...

2022-04-06 - CEPI partners with Japan's NEC Group for AI-designed ...

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the latest funding award...

2022-03-30 - CEPI to co-fund Vaxxinity’s pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants

CEPI to co-fund Vaxxinity's pivotal Phase 3 UB-612 heterologous booster trial to combat SARS-CoV-2 variants. Vaxxinity, Inc. April 6, 2022 ·8 min read.

2020-02-06 - In effort to develop coronavirus vaccine, outbreak expert sees ‘hardest problem’ of his career

As China struggles to contain an epidemic caused by a new coronavirus, science is racing to develop vaccines to blunt the outbreak’s impact. Central to the effort is CEPI — the Oslo, Norway-based Coalition for Epidemic Preparedness Innovations — a global partnership created to spearhead developm ...

2019-09-04 - NGT keeps moratorium plan in abeyance post MPCB ...

The recent Comprehensive Environmental Pollution Index (CEPI) score ranked Chandrapur as the second most polluted city in Maharashtra ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$104.4M292-6%N/A
#2
$87.9M296-1%N/A
#3
$47.5M2985%N/A
#4
N/A30020%N/A
#5
$101.6M30164%N/A

CEPI Executives


NameTitle
Kate KellandChief Scientific Writer
Joseph Simmonds-IsslerChief Of Staff
Claire WillmanDeputy Chief Of Staff
Inger SmithChief Accountant
Rebeka YasminExecutive Assistant to the CEO
Kristine RoseR&D Chief of Staff
Richard HatchettChief Executive Officer